RA Capital Management's Health Diagnostics Portfolio

Ceribell focuses on making electroencephalography accessible, efficient, and cost-effective.

Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.

Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.

Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.

Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

Somatus is a healthcare company that partners with health plans, health systems, nephrology, and primary care groups.

Genetix Biotherapeutics develops and delivers approved gene therapies for severe rare genetic diseases like sickle cell.

Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.

SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

Nature’s Toolbox is a biotechnology company that provides a proprietary host-independent biological manufacturing and development platform.

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.

Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

Akouos is a biotechnology company focusing on restoring and preserving hearing.

Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.